P&C

P&C Eyes on Earth

Q&A with Stephen Lathrope, Senior Vice President, Solutions, ICEYE, and Steven S...

From missile attacks to expropriations to coups, the geopolitical stage of 2025 ...

Experts also predict pharmaceutical tariffs will rekindle severe drug shortages, especially for generics, as the high tariff costs force generic manufacturers out of the U.S. market.

P&C Tariff Tensions

Cyber Risk

"This business continuity planning piece seems to be a pretty big oversight espe...

Sponsored By Nationwide

P&C Data Failures and Lawsuits Are Piling Up

Laws new and old are giving the plaintiffs’ bar new tools for cybersecurity cl...

P&C AI Accomplice

Q&A with Ashwin Kashyap, Chief Product Officer, CyberCube

Industry Our Most Read Articles of 2024

Leader’s Edge subscribers read dozens of articles published online in 2024, but they read these 10 articles the most

See all Cyber Risk

P&C Data Failures and Lawsuits Are Piling Up

Laws new and old are giving the plaintiffs’ bar new tools for cybersecurity class actions.

P&C Political Risk Starts at Home

An increasingly sharp partisan divide in the United States, coupled with major changes from the Trump administration, have heightened political risk among business leaders and insurers.

P&C New York Cybersecurity Obligations Expand

Starting this year, firms are subject to new requirements on vulnerability scans, access privileges, and multifactor authentication under the state’s amended cybersecurity rules.

P&C Risk Headwinds Blowing for Product Manufacturing

Supply chain disruptions, regulatory concerns, and cyber risk are changing the sector’s liability landscape in 2025.